Jamshid Maddahi MD FACC, FASNC

Interventional Cardiology

Clinical Professor, Medicine (Cardiology) and Molecular & Medical Pharmacology (Nuclear Medicine) UCLA School of Medicine

Join to view full profile

100 UCLA Medical PlzSte 410Los Angeles, CA 90024
Phone+1 310-824-4991
Fax+1 310-824-7082

Dr. Maddahi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maddahi's full profile Already have an account?

Education & Training

Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1977 - 1981
Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1975 - 1977
Tehran University of Medical Sciences School of MedicineClass of 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1977 - 2028
IN State Medical License 1977 - 1978
American Board of Nuclear Medicine Nuclear Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification CGM CLINICAL™, CompuGroup Medical, 2014
Fellow (FACC) American College of Cardiology

Clinical Trials

A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
COMPLETED
PHASE1
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
COMPLETED
PHASE1
A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
COMPLETED
PHASE3

Publications & Presentations

PubMed

Improved assessment of coronary artery disease in obese patients with flurpiridaz-F positron emission tomography myocardial perfusion imaging: A prespecified subgroup ...
Krishna K Patel, Jamshid Maddahi, Denis Agostini, Jeroen J Bax, Rob S B Beanlands
Journal of Nuclear Cardiology. 2026-07-01
1 citations
Diagnostic performance of F-18 flurpiridaz in women: A sub-study of the Aurora Phase 3 trial.
Stephen J Horgan, Gary V Heller, Jamshid Maddahi, Timothy M Bateman, Jeroen J Bax
Journal of Nuclear Cardiology. 2026-04-01
3 citations
Comparison, Agreement, and Significance Cutoffs ofF-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software Packages.
René R Sevag Packard, Christopher Buckley, C David Cooke, Jonathan B Moody, Jennifer M Renaud
Journal of Nuclear Medicine. 2025-11-03

Lectures

34th Annual Recent Advances in Clinical Nuclear Cardiology & Cardiac CT: Featuring Case Review with the Experts
American College of Cardiology Foundation, Washington, Dist Of Col - 5/3/2012

Press Mentions

Revolutionizing Cardiovascular Imaging with FlurpiridazFebruary 10th, 2025
GE HealthCare Moves PET/CT Scanner Production to United StatesOctober 24th, 2024
A Closer Look at How FDA's Flurpiridaz Approval Will Impact Nuclear CardiologyOctober 9th, 2024